Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of TLPPF will - over the next 2 Weeks and hit - by . In that time frame, TLPPF's share price is expected to range between - and -.
BearishAverageBullishTLPPF shares rose +0.32% in Monday, December 22, 2025's trading session, rising from a previous close of $7.77 to move at $7.79. The stock demonstrated notable intraday movement (see TLPPF's key stats for a full breakdown), fluctuating between $7.79 and $7.87, a +1.03% trading range. While recent weeks have seen some volatility, TLPPF has managed to secure a -18.85% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 4.8K shares changing hands, 521 more than the previous session. This amounted to $37.36K in total market activity.
Will TLPPF Continue Its Trend?
According to analyst ratings and projections for TLPPF, Telix Pharmaceuticals Limited shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for TLPPF currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the TLPPF stock forecast, now is not the best time to buy TLPPF stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on TLPPF covering social and institutional perspectives.
TLPPF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into TLPPF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 24.12% to 35.33%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 41.66%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.40%, maintains a neutral outlook for the long term. Insights into TLPPF's shareholder base show how institutional investors are positioning themselves during these momentum shifts

